{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:18:12Z","timestamp":1772612292110,"version":"3.50.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak is a major challenge for clinicians. SARS-CoV-2 infection results in coronavirus disease 2019 (COVID-19), and it is best known for its respiratory symptoms. It can also result in several extrapulmonary manifestations such as neurological complications potentially experienced during the course of COVID-19. The association of dermatomyositis (DM) with COVID-19 pathogenesis has not been well-studied. This study aimed to present a previously healthy 37-year-old man, a soldier by profession, with symptoms of DM on the 4th day from the onset of COVID-19. The patient presented DM symptoms with both skin and muscle manifestations. The patient suffered from cough, fever, and fatigue to begin with, and reverse-transcription polymerase chain reaction (RT-PCR) reported positive for SARS-CoV-2 infection. The laboratory findings showed, intra alia, elevated muscle enzymes CK 8253 U\/l (N: &amp;lt;145 U\/l), a positive test for myositis-specific autoantibodies (anti-Mi-2), electrodiagnostic tests exhibited features of myopathy, with the presence of muscle and skin symptoms. The patient improved with corticosteroids and immunosuppressive agent therapy. In summary, the association between COVID-19 and the development of multi-system autoimmune disorders such as DM remains unclear. Nevertheless, viral infections such as SARS-CoV-2 may likely serve as a trigger.<\/jats:p>","DOI":"10.3389\/fneur.2023.1122475","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T12:54:15Z","timestamp":1684500855000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case report: Unusual patient with dermatomyositis associated with SARS-CoV-2 infection"],"prefix":"10.3389","volume":"14","author":[{"given":"Joanna","family":"Niedzielska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Chaszczewska-Markowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Chojdak-\u0141ukasiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Berezowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemys\u0142aw","family":"Jazwiec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"B1","volume-title":"Merritt's Neurology","author":"Louis","year":"2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1016\/j.jtauto.2019.100018","article-title":"Polymyositis and dermatomyositis\u2014Challenges in diagnosis and management","volume":"2","author":"Yang","year":"2019","journal-title":"J Transl Autoimmun"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1179547619855370","DOI":"10.1177\/1179547619855370","article-title":"Dermatomyositis: an acute flare and current treatments","volume":"12","author":"Okogbaa","year":"2019","journal-title":"Clin Med Insights Case Rep."},{"key":"B4","unstructured":"Diagnosis and differential diagnosis of dermatomyositis and polymyositis in adults\u2014UpToDate\n            MillerML\n            Amato\n            AA\n            VleugelsRA\n          9642942UpToDate2021"},{"key":"B5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/annrheumdis-2020-219373","article-title":"European league against rheumatism (EULAR)\/American college of rheumatology (ACR) SLE classification criteria item performance","volume":"80","author":"Aringer","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"European league against rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B7","first-page":"1565","article-title":"Dermatomyositis","volume":"64","author":"Koler","year":"2001","journal-title":"Am Fam Physician."},{"key":"B8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19 and autoimmune diseases","volume":"33","author":"Liu","year":"2021","journal-title":"Curr Opin Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","article-title":"Autoimmune and inflammatory diseases following COVID-19","volume":"16","author":"Galeotti","year":"2020","journal-title":"Nat Rev Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"102314","DOI":"10.1016\/j.tmaid.2022.102314","article-title":"Systematic review of COVID-19 and autoimmune thyroiditis","volume":"47","author":"Tutal","year":"2022","journal-title":"Travel Med Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1007\/s10067-022-06227-7","article-title":"Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management","volume":"41","author":"Mehta","year":"2022","journal-title":"Clin Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S0140-6736(99)05157-0","article-title":"Dermatomyositis","volume":"10","author":"Callen","year":"2000","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaad.2019.05.105","article-title":"Dermatomyositis: Diagnosis and treatment","volume":"82","author":"Waldman","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"747116","DOI":"10.3389\/fimmu.2021.747116","article-title":"COVID-19 Disease and dermatomyositis: a mini-review","volume":"12","author":"Qian","year":"2022","journal-title":"Front Immunol."},{"key":"B15","unstructured":"Przeciwcia\u0142a swoiste dla zapalenia sk\u00f3rno-mie\u015bniowego (DM) - Artyku\u0142y przegladowe - Reumatologia - Medycyna Praktyczna dla lekarzy\n            FischerK\n          Medycyna Praktyczna2020"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e190010","DOI":"10.1148\/ryct.2019190010","article-title":"Comparison of original and 2018 Lake Louise criteria for diagnosis of acute myocarditis: results of a validation cohort","volume":"1","author":"Luetkens","year":"2019","journal-title":"Radiol Cardiothorac Imaging."},{"key":"B17","doi-asserted-by":"publisher","first-page":"021","DOI":"10.1016\/j.molimm.2021.06.021","article-title":"Untangling COVID-19 and autoimmunity: identification of plausible targets suggests multi organ involvement","volume":"3","author":"Mohkhedkar","year":"2021","journal-title":"Mol Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1186\/s12969-021-00570-w","article-title":"COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?","volume":"10","author":"Movahedi","year":"2021","journal-title":"Pediat Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/BOR.0000000000000844","article-title":"Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies","volume":"3","author":"De Santis","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"036","DOI":"10.1016\/j.jdcr.2021.04.036","article-title":"Dermatomyositis in a COVID-19 positive patient","volume":"5","author":"Ho","year":"2021","journal-title":"JAAD Case Reports."},{"key":"B21","first-page":"20","article-title":"Dermatomyositis during COVID-19 pandemic (a case series): is there a cause effect relationship?","volume":"68","author":"Gokhale","year":"2020","journal-title":"J Assoc Physicians India."},{"key":"B22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/rheumatology\/keab290","article-title":"Onset of dermatomyositis in close association with COVID-19\u2014A first case reported","volume":"3","author":"Borges","year":"2021","journal-title":"Rheumatology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/mus.27105","article-title":"COVID-19-associated myositis may be dermatomyositis","volume":"10","author":"Tanboon","year":"2021","journal-title":"Muscle Nerve."},{"key":"B24","doi-asserted-by":"publisher","first-page":"E57","DOI":"10.1002\/mus.27003","article-title":"COVID-19-associated myositis with severe proximal and bulbar weakness","volume":"62","author":"Zhang","year":"2020","journal-title":"Muscle Nerve."},{"key":"B25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007.\/s10072-020-04708-8","article-title":"Neuromuscular presentations in patients with COVID-19","volume":"3","author":"Paliwal","year":"2020","journal-title":"Neurol. Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"001","DOI":"10.1016\/j.jocn.2021.04.001","article-title":"Post-COVID 19 neurological syndrome: Implications for sequelae's treatment","volume":"5","author":"Camargo-Mart\u00ednez","year":"2021","journal-title":"J Clin Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic Manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"3","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007.\/s00115-021-01093-1","article-title":"Neuromuscular complications of SARS-CoV-2 infection\u2014Part 2: muscle disorders","volume":"92","author":"Lehmann","year":"2021","journal-title":"Nervenarzt"},{"key":"B29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002.\/jmv.26294","article-title":"Extrapulmonary complications of COVID-19: a multisystem disease?","volume":"93","author":"Zheng","year":"2021","journal-title":"J Med Virol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.4269\/ajtmh.20-0692","article-title":"Case report: rhabdomyolysis in a patient with COVID-19: a proposed diagnostic-therapeutic algorithm","volume":"103","author":"Sol\u00eds","year":"2020","journal-title":"Am J Trop Med Hyg."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1056\/NEJMC2009191","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N Eng J Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.1212\/WNL.0000000000009937","article-title":"Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry","volume":"3","author":"Romero-S\u00e1nchez","year":"2020","journal-title":"Neurology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1136\/annrheumdis-2020-217573","article-title":"Myositis as a manifestation of SARS-CoV-2","author":"Beydon","year":"2021","journal-title":"Ann Rheum Dis."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1122475\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T12:54:22Z","timestamp":1684500862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1122475\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":33,"alternative-id":["10.3389\/fneur.2023.1122475"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1122475","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"article-number":"1122475"}}